Camrelizumab-based therapies for the treatment of advanced lung cancer: a prospective, open-label, multicenter, observational, real-world study

Dong Zhao(Beijing University of Chemical Technology), Kangsheng Gu(Anhui Medical University), Xiaofei Cheng(Anqing City Hospital), Huaidong Cheng(Anhui Medical University), Xiaoyang Xia, Man Li(Linyi People's Hospital), Huan Chen(Beth Israel Deaconess Medical Center), Hui Liang(Jinan University), Kehai Feng, Xuhong Min(Xi'an Chest Hospital), Hua Xie, Minghong Bi(First Affiliated Hospital of Bengbu Medical College), Zhiqiang Hu(Jiangsu University), Yanbei Zhang(Anhui Medical University), Ling Xu(Shanghai University of Traditional Chinese Medicine), Shuhong Wang, Qisheng Cao(Anshan Hospital), Fan Wang(Anhui Medical University), Jinhua Zhou(Soochow University), Rui Wang(Xi'an Chest Hospital), Xiaosi Chen
Frontiers in Immunology
March 7, 2025
Cited by 2


Related Papers